Omnicell, Inc. (NASDAQ:OMCL) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Kathleen Nemeth – Senior Vice President-Investor Relations Randall Lipps – Founder, Chairman, President and Chief Executive Officer Nchacha Etta – Executive Vice President and Chief Financial Officer Conference Call Participants Stan Berenshteyn – Wells Fargo Matt Hewitt – Craig-Hallum Scott Schoenhaus – KeyBanc Jessica Tassan – Piper Sandler Jenny Shen – BTIG Anna Kruszenski – Barclays Bill Sutherland ...

May 2, 2024 This presentation contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"), including Q1-2024 non-GAAP gross margin, non-GAAP operating expense, nonGAAP EBITDA, and non-GAAP earnings per share, 2017 and Q1-2024 liquidity and 2017 and Q1-2024 net debt/EBITDA, guidance with respect to 2024 non-GAAP EBITDA and non-GAAP earnings per share. Reconciliations of the 2017 and Q1-2024 non-GAAP financial measures to the most directly comp ...

Omnicell (OMCL) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to earnings of $0.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 137.50%. A quarter ago, it was expected that this Omnicell Inc. Would post earnings of $0.17 per share when it actually produced earnings of $0.33, delivering a surprise of 94.12%.Over the last four quarters, th ...

Exhibit 99.1 Contact: Kathleen Nemeth Omnicell, Inc. Senior Vice President, Investor Relations 4220 North Freeway 650-435-3318 Fort Worth, TX 76137 Kathleen.Nemeth@Omnicell.com Omnicell Announces First Quarter 2024 Results Results exceed prior first quarter guidance across all metrics Total GAAP revenues of $246 million FORT WORTH, Texas -- May 2, 2024 -- Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, t ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m. ET. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About Omnicell Since 1992, Omnicell has been committed to transforming pharmacy care through outcomes-centri ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-33043 OMNICELL, INC. (Exact name of regis ...

zhihao/Moment via Getty Images Investment thesis Omnicell (NASDAQ:OMCL) has built a highly differentiated portfolio of products and services in the medication dispensing market that puts it, in my opinion, in a strongly advantageous position as the company is building a strong moat that will allow it to stay highly profitable and enjoy high and stable revenue streams in the long term, which should translate into significant (and hopefully steady) returns for investors once a more mature stage is reached. Th ...

Omnicell, Inc. (OMCL) reported fourth-quarter 2023 adjusted earnings per share (EPS) of 33 cents, in line with the year-over-year figure. However, the metric beat the Zacks Consensus Estimate of 17 cents.Adjustments include one-time expenses like share-based compensations, the amortization of acquired intangibles, acquisition-related expenses, executive transition costs, severance-related expenses and others.GAAP loss was 32 cents per share in the quarter under review compared with 64 cents in the prior-yea ...

Omnicell, Inc. (NASDAQ:OMCL) Q4 2023 Earnings Conference Call February 8, 2024 8:30 AM ET Company Participants Kathleen Nemeth - SVP of IR Randall Lipps - Chairman, President, CEO and Founder Nchacha Etta - EVP and CFO Conference Call Participants Stan Berenshteyn - Wells Fargo Anne Samuel - JPMorgan Scott Schoenhaus - KeyBanc Allen Lutz - Bank of America Matt Hewitt - Craig-Hallum Capital Group David Larsen - BTIG Stephanie Davis - Barclays Bill Sutherland - The Benchmark Company Jessica Tassan - Piper San ...

Omnicell (OMCL) is well-poised for growth in the coming quarters, backed by the execution of its vision to transform the pharmacy care delivery model and deliver mission-critical medication management solutions for customers globally. The company is closely managing the cost structure with several initiatives, which are set to benefit its key metrics.Macroeconomic headwinds are resisting the full impact of expense containment efforts.In the past three months, this Zacks Rank #3 (Hold) stock has declined 21. ...